Verastem To Present Preclinical Data At SITC 2015

BOSTON--(BUSINESS WIRE)--Verastem, Inc. (NASDAQ:VSTM), focused on discovering and developing drugs to treat cancer by the targeted killing of cancer stem cells, today announced two poster presentations at the Society for Immunotherapy of Cancer (SITC) 30th Anniversary Annual Meeting & Associated Programs being held November 4-8, in National Harbor, Maryland.

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC